Tag:
SymBio Pharmaceuticals
Latest Headlines
Latest Headlines
SymBio garners $24M VC round for cancer drugs, in-licensing
Cephalon has joined hands with JAFCO, a Japanese private equity group, to inject $24 million into SymBio Pharmaceuticals, a Japanese biotech company studying its lead drug for non-Hodgkin's lymphoma
